To assess the performance of serum sFRP2 as a diagnostic biomarker in distinguishing breast cancer patients from normal healthy controls, receiver operating characteristic/area under the curve (ROC/AUC) was performed (Figure 1(b)). The gene discussed is SFRP2; the disease is breast carcinoma.